• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Mankind Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 38451.0
  • ISIN : INE634S01028
2,424.75 -27 (-1.12%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    2,411.05

  • Today’s High

    2,485.00

  • Open

    2,467.95

  • Perv Close

    2,452.15

  • 52W Low

    1,901.05

  • 52W High

    3,054.80

Key Indicators

  • P/E(TTM)

    51.70

  • Mar.Cap (₹Cr.)

    100,039.98

  • Div & Yield %

    0.00

  • Book Value(₹)

    334.17

  • Debt-Equity Ratio

    -1.12

  • AGM Date

    28-Mar-2025

  • EPS

    46.87

  • P/E Ratio

    51.70

Financials Ratios

  • Debt-Equity Ratio

    0.02

  • Mar.Cap (₹Cr.)

    100,039.98

  • RONW (%)

    23.12

  • ROCE (%)

    27.91

Score Board

  • Equity (₹ in Cr.)

    41.26

  • BV (₹)

    334.20

  • Sales( ₹ in Cr.)

    9,264.81

  • NP (in Cr.)

    1,715.30

  • NP Var(%)

    41.0

  • Div%

    0.0

  • CPS (₹)

    49.30

  • EPS (₹)

    41.60

  • Traded Value (₹ in Lakhs)

    99,973.97

  • 52 Week High

    3,054.80

  • 52 Week Low

    1,901.05

  • Price BSE

    2423.0

  • Price NSE

    2,425.00

  • Market Capital( in Cr.)

    99,973.97

  • P/C Ratio

    49.20

  • P/E Ratio

    58.30

  • Price Vs.BV

    41.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 9,264.81 8,127.15 7,486.22 5,523.18 4,794.41 -
Excise Duty 9,218.55 8,082.54 7,448.21 5,388.89 4,651.89 -
Net Sales 9,264.81 8,127.15 7,486.22 5,523.18 4,794.41 -
Other Income 266.64 162.78 203.81 154.50 93.85 -
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 -
Total Income 9,531.45 8,289.94 7,690.04 5,677.68 4,888.26 -
EXPENDITURE :
Raw Materials 9,218.55 8,082.54 7,448.21 5,388.89 4,651.89 -
Power & Fuel Cost 9,218.55 8,082.54 7,448.21 5,388.89 4,651.89 -
Employee Cost 1,982.10 1,701.38 1,462.76 1,167.42 991.47 -
Other Manufacturing Expenses 136.18 168.95 131.50 192.32 185.55 -
Selling & Administrative Expenses 1,699.55 1,539.07 1,378.52 905.53 696.80 -
Miscellaneous Expenses 136.18 168.95 131.50 192.32 185.55 -
Less : Pre-operative Expenses Capitalised :
Total Expenditure 7,271.88 6,727.10 5,818.60 4,237.47 3,623.34 -
Operating Profit 213.57 175.62 153.93 103.86 104.22 -
Interest 14.57 27.75 47.12 7.98 10.62 -
Gross Profit 2,259.57 1,562.84 1,871.44 1,440.21 1,264.92 -
Depreciation 317.61 269.58 123.33 78.19 61.77 -
Profit Before Tax 2,259.57 1,562.84 1,871.44 1,440.21 1,264.92 -
Tax 415.39 296.00 429.03 346.99 336.58 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax 24.18 30.30 52.98 8.84 -35.11 -
Reported Net Profit 1,823.41 1,248.26 1,389.42 1,084.37 958.23 -
Extraordinary Items 2,259.57 1,562.84 1,871.44 1,440.21 1,264.92 -
Adjusted Net Profit 1,823.41 1,248.26 1,389.42 1,084.37 958.23 -
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 -
Statutory Appropriations 0.00 0.00 0.00 0.00 302.44 -
P & L Balance carried down 1,823.41 1,248.26 1,389.42 1,084.37 958.23 -
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 755.00 -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 7.55 -
Earnings Per Share-Unit Curr 45.52 31.16 34.68 27.07 23.92 -
Book Value 0.00 0.00 0.00 0.00 302.44 -
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 302.44 -

Shareholding Pattern

  • Promoter Group

    72.71%

  • Public Share Holding

    27.29%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 74,921,805 18.16 74,921,805 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 225,038,807 54.55 225,038,807 3
Others 0 0.00 0 0
Sub Total 299,960,612 72.71 299,960,612 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 55,029,940 13.34 55,029,940 542
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 9,123,143 2.21 9,123,143 13
Mutual Funds / UTI 32,310,902 7.83 32,310,902 30
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 4,185,459 1.01 4,185,459 39
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 100,649,444 24.40 100,649,444 624
2] Non Institution
Bodies Corporate 4,747,178 1.15 4,747,178 936
Clearing Members 1,383 0.00 1,383 7
Directors of their Relatives 0 0.00 0 0
Employees 50,094 0.01 50,094 9
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 309,419 0.08 309,419 2,875
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 225,018 0.05 225,018 3,454
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 0 0.00 0 0
Individuals holding nominal share capital up to Rs. 1 lakh 6,610,183 1.60 6,610,183 163,352
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 5,428 0.00 5,428 10
Others 8,140 0.00 8,140 1
Sub Total 11,956,843 2.90 11,956,843 170,644
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 412,566,899 100.00 412,566,899 171,281

Company Background

Mankind Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Mankind Pharma Ltd
  • BSE Code : 38451.0
  • ISIN : INE634S01028

  • Incorporation Year

    1991

  • Registered Office

    208 Okhla Industrial Estate
    Phase-III, New Delhi,
    New Delhi-110020

  • Telephone

    91-11-47476600

  • FAX

  • Chairman

    RAMESH CHAND JUNEJA

  • Managing Director

  • Company Secretary

    Hitesh Kumar Jain

  • Auditor

    S R Batliboi & Co LLP/Bhagi Bhardwaj Gaur & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Mankind Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Mankind Pharma 2,423.15 9,531.45 9,264.81 49.53 25.77
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92